BIO Earnings Bio-Rad Laboratories, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -19.55 | 2026-04-30 | 10-Q |
| FY 2025 | 2025-12-31 | 27.85 | 2026-02-13 | 10-K |
| Q3 2025 | 2025-09-30 | 1.46 | 2025-10-29 | 10-Q |
| Q2 2025 | 2025-06-30 | 13.84 | 2025-07-31 | 10-Q |
| Q1 2026 | 2025-03-31 | 2.29 | 2026-04-30 | 10-Q |
| FY 2025 | 2024-12-31 | -65.36 | 2026-02-13 | 10-K |
| Q3 2025 | 2024-09-30 | -39.89 | 2025-10-29 | 10-Q |
| Q2 2025 | 2024-06-30 | -62.61 | 2025-07-31 | 10-Q |
| Q1 2025 | 2024-03-31 | 13.45 | 2025-05-01 | 10-Q |
| FY 2025 | 2023-12-31 | -21.82 | 2026-02-13 | 10-K |
| FY 2024 | 2023-09-30 | 3.64 | 2025-02-14 | 10-K |
| FY 2024 | 2023-06-30 | -39.59 | 2025-02-14 | 10-K |
| FY 2024 | 2023-03-31 | 2.32 | 2025-02-14 | 10-K |
| FY 2023 | 2022-12-31 | -121.79 | 2024-02-16 | 10-K |
| FY 2023 | 2022-09-30 | -5.48 | 2024-02-16 | 10-K |
| FY 2023 | 2022-06-30 | -31.05 | 2024-02-16 | 10-K |
| FY 2023 | 2022-03-31 | -112.50 | 2024-02-16 | 10-K |
| FY 2023 | 2021-12-31 | 140.83 | 2024-02-16 | 10-K |
| FY 2022 | 2021-09-30 | 130.02 | 2023-02-17 | 10-K |
| FY 2022 | 2021-06-30 | 30.41 | 2023-02-17 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.